Vanaclocha F, Carrascosa JM, Caloto T, Elías I, Echave M, Tencer T
Budget impact analysis of apremilast on moderate to severe psoriasis in Spain
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Gonzalez C, Almodóvar R, Caloto T, Echave M, Elías I, Tencer T
Cost-utility of aprelimast for the treatment of psoriatic arthritis patients in Spain
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Carrascosa JM, Vanaclocha F, Caloto T, Echave M, Oyagüez I, Tencer T
Cost-utility analysis of apremilast for the treatment of moderate to severe psoriasis in Spain
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Almodóvar R, Gonzalez C, Caloto T, Elías I, Oyagüez I, Tencer T
Budget impact analysis of apremilast in patients with psoriatic arthritis in Spain
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Ariza R, van Walsem A, Canal C, Roldán C, Betegón L, Oyagüez I, Janssen K
Análisis de minimización de costes de abatacept subcutáneo en el tratamiento de la artritis reumatoide en España
Farm Hosp. 2014;38(4):257-65
Gratacos J, Dauden E, Gómez-Reino J, Moreno JC, Casado MA, Rodriguez-Valverde V
Health-related quality of life in psoriatic arthritis patients in Spain
Reumatol Clin. 2014;10(1):25-31
Ariza-Ariza R, Van Walsem A, Canal C, Roldán C, Betegón L, Oyagüez I, Janssen K
Cost-minimization analysis of subctuaneous abatacept in the treatment of rheumatoid arthritis in Spain
16th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013
Pujol RM, Puig L, Daudén E, Sánchez-Carazo JL,Toribio J, Vanaclocha F,Yébenes M, Sabater E, Casado MA, Caloto MT, Aragón B on behalf of the VACAP Study investigators
Mental-health self-assessment in patients with moderate to severe psoriasis. An observational, multicentre study of 1,164 patients in Spain, The VACAP study
Actas Dermosifiliogr. 2013;104:897-903
Daudén E, Pujol R, Sánchez-Carazo JL, Toribio J, Vanaclocha F, Puig L, Yébenes M, Sabater E, Casado MA, Caloto MT, Aragón B